Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Nov;6(Suppl 1):S41.
doi: 10.21037/atm.2018.09.47.

Re-biopsy in lupus nephritis

Hans-Joachim Anders  1
Affiliations
Editorial

Re-biopsy in lupus nephritis

Hans-Joachim Anders. Ann Transl Med. 2018 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author and the last author of the discussed paper are both board members of the Lupus Nephritis Trials Network that has an academic interest in exploring the diagnostic potential of re-biopsies in the management of patients with lupus nephritis.

Figures

Figure 1
Figure 1
Different timings for kidney biopsies in lupus nephritis. Re-biopsies in lupus nephritis can be assist decision making at different time points in the disease course of lupus nephritis (see Table 1). A re-biopsy can provide important information not only in patients with disease flare or persistent proteinuria but also during suspected clinical remission. The optimal time point for a post-induction protocol biopsy is not known. CKD, chronic kidney disease.
See this image and copyright information in PMC

Comment on

References

    1. Kaul A, Gordon C, Crow MK, et al. Systemic lupus erythematosus. Nat Rev Dis Primers 2016;2:16039. 10.1038/nrdp.2016.39 - DOI - PubMed
    1. Anders HJ, Rovin B. A pathophysiology-based approach to the diagnosis and treatment of lupus nephritis. Kidney Int 2016;90:493-501. 10.1016/j.kint.2016.05.017 - DOI - PubMed
    1. Romagnani P, Remuzzi G, Glassock R, et al. Chronic kidney disease. Nat Rev Dis Primers 2017;3:17088. 10.1038/nrdp.2017.88 - DOI - PubMed
    1. Anders HJ, Jayne DR, Rovin BH. Hurdles to the introduction of new therapies for immune-mediated kidney diseases. Nat Rev Nephrol 2016;12:205-16. 10.1038/nrneph.2015.206 - DOI - PubMed
    1. De Rosa M, Azzato F, Toblli JE, et al. A prospective observational cohort study highlights kidney biopsy findings of lupus nephritis patients in remission who flare following withdrawal of maintenance therapy. Kidney Int 2018;94:788-94. 10.1016/j.kint.2018.05.021 - DOI - PubMed